Results for tag: "Oncology NGS"

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment. The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more